Mature B cells and mesenchymal stem cells control emergency myelopoiesis

• Published in: Life science alliance 2023-04, Vol.6 (4), p.e202301924
• Main Authors: Lim, Vivian Y, Feng, Xing, Miao, Runfeng, Zehentmeier, Sandra, Ewing-Crystal, Nathan, Lee, Moonyoung, Tumanov, Alexei V, Oh, Ji Eun, Iwasaki, Akiko, Wang, Andrew, Choi, Jungmin, Pereira, João P
• Format: Article
• Language: English
• Subjects: B-Lymphocytes - metabolism; Humans; Inflammation - metabolism; Interleukin-7; Mesenchymal Stem Cells - metabolism; Myelopoiesis
• ISSN: 2575-1077; 2575-1077
• DOI: 10.26508/lsa.202301924

Systemic inflammation halts lymphopoiesis and prioritizes myeloid cell production. How blood cell production switches from homeostasis to emergency myelopoiesis is incompletely understood. Here, we show that lymphotoxin-β receptor (LTβR) signaling in combination with TNF and IL-1 receptor signaling in bone marrow mesenchymal stem cells (MSCs) down-regulates expression to shut down lymphopoiesis during systemic inflammation. LTβR signaling in MSCs also promoted CCL2 production during systemic inflammation. Pharmacological or genetic blocking of LTβR signaling in MSCs partially enabled lymphopoiesis and reduced monocyte numbers in the spleen during systemic inflammation, which correlated with reduced survival during systemic bacterial and viral infections. Interestingly, lymphotoxin-α1β2 delivered by B-lineage cells, and specifically by mature B cells, contributed to promote down-regulation and reduce MSC lymphopoietic activity. Our studies revealed an unexpected role of LTβR signaling in MSCs and identified recirculating mature B cells as an important regulator of emergency myelopoiesis.